Veloxis Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Veloxis Pharmaceuticals's estimated annual revenue is currently $15.5M per year.
- Veloxis Pharmaceuticals's estimated revenue per employee is $147,619
- Veloxis Pharmaceuticals's total funding is $60M.
Employee Data
- Veloxis Pharmaceuticals has 105 Employees.
- Veloxis Pharmaceuticals grew their employee count by 15% last year.
Veloxis Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP, Legal and General Counsel | Reveal Email/Phone |
3 | VP, Head Clinical Development and Operations | Reveal Email/Phone |
4 | Director Clinical Operations | Reveal Email/Phone |
5 | Chief Operations Officer | Reveal Email/Phone |
6 | Director IT | Reveal Email/Phone |
7 | Senior Director Finance and Controller | Reveal Email/Phone |
8 | Executive Director, Medical Strategy and Operations | Reveal Email/Phone |
9 | Executive Director, Human Resources | Reveal Email/Phone |
10 | Senior Manager, Sales Operations | Reveal Email/Phone |
Veloxis Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $11.2M | 63 | 7% | N/A | N/A |
#2 | $5099.8M | 32902 | -4% | N/A | N/A |
#3 | $1.7M | 11 | 0% | N/A | N/A |
#4 | $0.6M | 4 | -56% | N/A | N/A |
#5 | N/A | 15 | 7% | N/A | N/A |
#6 | $0.9M | 11 | -39% | N/A | N/A |
#7 | $1.7M | 9 | 0% | N/A | N/A |
#8 | $0.6M | 3 | 0% | N/A | N/A |
#9 | $4.8M | 31 | -6% | N/A | N/A |
#10 | $6.4M | 36 | 6% | N/A | N/A |
What Is Veloxis Pharmaceuticals?
Veloxis is a specialty pharmaceutical company with a singular focus on meeting the needs of the global transplant community. Our roots stem from an endeavor launched by Danish pharmaceutical company H. Lundbeck A/S to enhance the delivery of a specific class of drugs. This led to a proprietary formulation technology, MeltDose®, which is designed to potentially address issues of bioavailability of poorly water-soluble drugs. To commercialize the technology, LifeCycle Pharma A/S was formed in June 2002. In July 2011, LifeCycle Pharma became Veloxis Pharmaceuticals A/S
keywords:N/A
$60M
Total Funding
105
Number of Employees
$15.5M
Revenue (est)
15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Veloxis Pharmaceuticals News
... Kasei Group agreed to acquire Danish pharma company Veloxis Pharmaceuticals through its Danish subsidiary Asahi Kasei Pharma Denmark.
... agreement with Veloxis Pharmaceuticals Inc. for FR104, anti-CD28, ... turnover linked to the Company's pharmaceutical partnerships and...
Other Companies in Cary
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $21.1M | 105 | 67% | N/A |
#2 | $29.2M | 108 | 61% | N/A |
#3 | $29.3M | 111 | 2% | N/A |
#4 | $16.1M | 111 | N/A | N/A |
#5 | $30M | 111 | -1% | N/A |